Showing 2751-2760 of 7117 results for "".
Physician Spotlight: Judith Hellman, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-judith-hellman-md/20956/Maximize Your Link-Building Opportunities
https://practicaldermatology.com/topics/practice-management/maximize-your-link-building-opportunities/20947/Innovative link building ideas to help bolster your search rankings.The Next Big Thing: Aesthetics in 2016
https://practicaldermatology.com/topics/practice-management/the-next-big-thing-aesthetics-in-2016/21035/Industry leaders share their predictions for what we will be talking about this year in aesthetic dermatology.Reach Your Customers
https://practicaldermatology.com/topics/practice-management/reach-your-customers/21079/Strategic messaging and marketing opportunities for your practice.Success Tips: Selling Great Aesthetic Value for a Fair Price
https://practicaldermatology.com/topics/practice-management/success-tips-selling-great-aesthetic-value-for-a-fair-price/21094/How to convey product or service value to patients to close a sale with confidence.New Products / Therapeutics Focus: Skin Cancer
https://practicaldermatology.com/topics/practice-management/new-products-therapeutics-focus-skin-cancergy/21120/Currents
https://practicaldermatology.com/topics/practice-management/currents/21127/Consolidating Regulatory Penalties: Introducing MIPS
https://practicaldermatology.com/topics/practice-management/consolidating-regulatory-penalties-introducing-mips/21140/A new system will consolidate Meaningful Use, Value-Based Modifier, and PQRS into one program. Here's what you need to know.Pruritus: A Marker For Cancer?
https://practicaldermatology.com/topics/practice-management/pruritus-a-marker-for-cancer/21181/Though the relationship is well known, new studies validate concerns regarding the link between pruritus and malignancy.Biologics and Pediatric Psoriasis
https://practicaldermatology.com/topics/practice-management/biologics-and-pediatric-psoriasis/21196/Though data has been lacking in recent years, the use of biologics in pediatric and adolescent patients deserves more consideration.